Document:

Exhibit10.2

Exhibit 10.2

EMPLOYMENT SEPARATION AGREEMENT
This Employment Separation Agreement (the “Agreement”) is effective as of October 20, 2014, and is made by and between PDI, Inc., a Delaware corporation (the “Company”), having its principal place of business at 300 Interpace Parkway, Parsippany, New Jersey 07054, and Graham G. Miao, MBA, Ph.D., residing at [                                                    ] (the “Executive”), collectively referred to as the “Parties,” pursuant to which the Parties agree:
1.    Employment.    In consideration of and conditioned upon the Executive’s execution of a Confidential Information, Non-Disclosure, Non-Solicitation, and Rights to Intellectual Property Agreement acceptable to the Company and substantially in the form attached hereto as Exhibit A, the Company will employ the Executive as Chief Financial Officer, Executive Vice President of the Company.  The Parties acknowledge and agree that Executive’s employment with the Company is “at will” and that Executive’s employment may be terminated by Executive or the Company at any time, for any reason or for no reason.  
		
	2.
	Compensation and Benefits Payable Upon Involuntary Termination without Cause or Resignation for Good Reason.

		
	a.
	Triggering Event.    In further consideration for Executive’s employment, Executive will receive the compensation and benefits set forth in Section 2(b) if the following requirements (hereinafter referred to as the “Triggering Event”) are met:

		
	i.
	Executive’s employment is terminated involuntarily by the Company at any time for reasons other than death, Total Disability, or Cause,as defined in this Agreement,or Executive resigns from employment for Good Reason, as defined in this Agreement; and

		
	ii.
	As of the 45thday following his termination date, Executive has executed and delivered to the Company, a Severance Agreement and General Release acceptable to the Company (the “Release”),and thereafter, any applicable revocation period has expired and Executive has not revoked the Release during such revocation period. Such Release shall include a release of all claims against the Company, all affiliated and related entities and/or persons deemed necessary by the Company.  The Release may also include Confidentiality, Non-Disparagement, No-Reapply, Tax Indemnification, and/or other appropriate terms.  

		
	b.
	Compensation and Benefits.Following the occurrence of a Triggering Event, the Company will provide the following compensation and benefits to Executive:

1

		
	i.
	The Company will pay Executive a lump sum payment equal to the product of twelve (12) times Executive’s Base Monthly Salary (excluding incentives, bonuses, and other compensation), plus the average of the annual amounts paid to Executive under any cash-based incentive or bonus plan in which Executive participates with respect to the last three (3) full fiscal years of Executive’s participation in such plan prior to the date of termination of Executive’s employment with the Company (or, if Executive’s number of full fiscal years of participation in any such plan prior to the date of termination of Executive’s employment is less than three (3), the average of the annual amounts paid to Executive over the number of full fiscal years of Executive’s participation in such plan prior to the date of termination of Executive’s employment).  Subject to Section 2(c) below, such payment shall be made within sixty (60) days after Executive’s termination date.      Notwithstanding the foregoing, if the 60 day period following the Executive’s termination ends in a calendar year after the year in which the Executive’s Employment terminates, the Severance Payment shall be made no earlier than the first day of such later calendar year.      

		
	ii.
	The Company agrees to pay the COBRA premiums for health and/or dental coverage under its group plans to provide continued coverage of health and/or dental benefits for up to twelve (12) months beginning on Executive’s termination date and ending on the earlier of either:  (A) the first anniversary of Executive’s termination date; or (B) the date on which Executive becomes eligible for other group health coverage.

		
	c.
	Delay of Payment to Comply with Code Section 409A. Notwithstanding anything herein to the contrary, if at the time of Executive’s termination of employment with the Company, Executive is a “specified employee” within the meaning of Code Section 409A, and the regulations promulgated thereunder, then if and to the extent required in order to avoid the imposition on Executive of any excise tax under Code Section 409A the Company shall delay the commencement of such payments (without any reduction) by a period of six(6) months after Executive’s termination date.  Any payments that would have been paid during such six (6) month period but for the provisions of the preceding sentence shall be paid in a lump sum to Executive six (6) months and one (1) day after Executive’s termination date.  The 6-month payment delay requirement of this Section 2(c) shall apply only to the extent that the payments under this Section 2 are subject to Code Section 409A.  With respect to payments or benefits under this Agreement that are subject to Code Section 409A, whether Executive has had a termination

2

of employment shall be determined in accordance with Code Section 409A and applicable guidance issued thereunder.
		
	d.
	Limitation of Payments.  If any payment or benefit due under this Agreement, together with all other payments and benefits Executive receives or is entitled to receive from the Company or any of its Affiliates, would (if paid or provided) constitute an excess parachute payment (within the meaning of Section 280G(b)(1) of the Code), the amounts otherwise payable and benefits otherwise due under this Agreement will be limited to be minimum extent necessary to ensure that no portion thereof will fail to be tax-deductible to the  Company by reason of Section 280G of the Code.  The determination of whether any payment or benefit would (if paid or provided) constitute an excess parachute payment will be made by the Board, in its sole discretion.  Any such reduction in the preceding sentence shall be made in the following order: (i) first, any future cash payments (if any) shall be reduced (if necessary, to zero); (ii) second, any current cash payments shall be reduced (if necessary, to zero); (ii) third, all non-cash payments (other than equity or equity derivative related payments) shall be reduced (if necessary, to zero); and (iv) fourth, all equity or equity derivative payments shall be reduced.Notwithstanding the foregoing, the Company shall use commercially reasonable efforts to bring the issue to a shareholder vote in accordance with Section 280G(b)(5) of the Code and the Treasury Regulations thereunder.    

		
	a.
	Section 409A Compliance.  The following rules shall apply, to the extent necessary, with respect to distribution of the payments and benefits, if any, to be provided to the Executive under this Agreement. This Agreement is intended to comply with or be exempt from Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) and the parties hereto agree to interpret, apply and administer this Agreement in the least restrictive manner necessary to comply therewith and without resulting in any increase in the amounts owed hereunder by the Company.  Subject to the provisions in this Section, the severance payments pursuant to this Agreement shall begin only upon the date of the Executive’s “separation from service” which occurs on or after the date of the Executive’s termination of employment.   It is intended that each installment of the severance payments and benefits provided under this Agreement shall be treated as a separate “payment” for purposes of Section 409A. 

All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A, to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirements that (i) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses

3

eligible for reimbursement in any other calendar year, (ii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred and (iii) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit.  Notwithstanding anything herein to the contrary, the Company shall have no liability to the Executive or to any other person if the payments and benefits provided in this Agreement that are intended to be exempt from or compliant with Section 409A are not so exempt or compliant.  
3.    Other Compensation.
		
	a.
	Except as may be provided under this Agreement, any benefits to which Executive may be entitled pursuant to the plans, policies and arrangements of the Company shall be determined and paid in accordance with the terms of such plans, policies, and arrangements, and Executive shall have no right to receive any other compensation or benefits, or to participate in any other plan or arrangement, following the termination of Executive’s employment by either party for any reason.

		
	b.
	Notwithstanding any provision contained herein to the contrary, in the event of any termination of employment, the Company shall pay Executive his or her earned, but unpaid, base salary within ten (10) days of Executive’s termination date and shall reimburse Executive for any accrued, but unpaid, reasonable business expenses, in each case, earned or accrued as of the date of termination.  Executive shall submit documentation of any business expenses within ninety (90) days of his or her termination date and any reimbursements of such expenses that are taxable to the Executive shall be made on or before the last day of the year following the year in which the expense was incurred, the amount of the expense eligible for reimbursement during one year shall not affect the amount of reimbursement in any other year, and the right to reimbursement shall not be subject to liquidation or exchange for another benefit.

		
	4.
	Withholding.    All amounts payable under this Agreement shall be subject to customary withholding and other employment taxes, and shall be subject to such other withholding as may be required in accordance with the terms of this Agreement or applicable law.

		
	5.
	Confidentiality, Non-Solicitation and Covenant Not to Compete Agreement.     In the event Executive’s employment with the Company is terminated by either party for any reason, Executive shall continue to be bound by the Confidential Information, Non-Disclosure, Non-Solicitation, and Rights to Intellectual Property Agreement signed at or about the time this Agreement is executed and/or the Confidentiality, Non-Solicitation

4

and/or Covenant Not to Compete Agreement most recently signed by Executive prior to the termination date for the period set forth therein.
		
	6.
	Successors and Assigns.  This Agreement is personal to Executive and may not be assigned by Executive without the written consent of the Company; provided, however, that if Executive is entitled to the payments of this Agreement and Executive dies before Executive has received all such payments, the unpaid payments will be paid to Executive’s estate on the same terms and conditions as described in this Agreement.  This Agreement will be binding upon and inure to the benefit of the Company and its successors and assigns. This Agreement will remain in full force and effect notwithstanding any Change of Control and in the case of any merger or consolidation, if not terminated on or as of the effective date of any such merger, will be the obligation of the surviving entity.

7.    Definitions.
a.    Cause shall mean (i) the failure of Executive to use Executive’s best efforts in accordance with Executive’s position, skill and abilities to achieve Executive’s goals as periodically set by the Company and such failure shall not be cured by the Executive within thirty (30) days written notice from the Company to the Executive specifying such failure; (ii) the failure by Executive to comply with the following reasonable instructions of the Chief Executive Officer and/or the Company’s Board of Directors (the Board”); (iii) a material breach by Executive of any of the terms or conditions of this Agreement and such breach shall not be cured by the Executive within thirty (30) days written notice from the Company to the Executive specifying such failure; (iv) the failure by Executive to adhere to the Company’s documented policies and procedures; (v) breach by Executive of any Confidentiality, Non-Solicitation and/or Covenant Not to Compete signed by Executive; (vi) the failure of Executive to adhere to moral and ethical business principles consistent with the Company’s Code of Business Conduct and Guidelines on Corporate Governance as in effect from time to time; (vii) Executive’s conviction of a criminal offense (including the entry of a guilty or nolo contendere plea); (viii) any documented act of material dishonesty or fraud by the Executive in the commission of his or her duties; or (ix) Executive engages in an act or series of acts constituting misconduct resulting in a misstatement of the Company’s financial statements due to material non-compliance with any financial reporting requirement within the meaning of Section 304 of The Sarbanes-Oxley Act of 2002.
b.    Base Monthly Salary shall mean an amount equal to one-twelfth of Executive’s then current annual base salary.  Base Monthly Salary shall not include incentives, 

5

bonus(es), health and welfare benefits, car allowances, long term disability insurance or any other compensation or benefit provided to executive employees of the Company.
c.    Change of Control shall mean: (i) any merger by the Company into another corporation or corporations which results in the stockholders of the Company immediately prior to such transaction owning less than 51% of the surviving corporation; (ii) any acquisition (by purchase, lease or otherwise) of all or substantially all of the assets of the Company by any person, corporation or other entity or group thereof acting jointly; (iii) the acquisition of beneficial ownership of voting securities of the Company (defined as common stock of the Company or any securities having voting rights that the Company may issue in the future) or rights to acquire voting securities of the Company (defined as including, without limitation, securities that are convertible into voting securities of the Company (as defined above) and rights, options, warrants and other agreements or arrangements to acquire such voting securities) by any other person, corporation or other entity or group thereof acting jointly, in such amount or amounts as would permit such person, corporation or other entity or group thereof acting jointly to elect a majority of the members of the Board, as then constituted; or (iv) the acquisition of beneficial ownership, directly or indirectly, of voting securities and rights to acquire voting securities having voting power equal to 51% or more of the combined voting power of the Company’s then outstanding voting securities by any person, corporation or other entity or group thereof acting jointly.  Notwithstanding the preceding sentence, any transaction that involves a mere change in identity, form or place of organization with the meaning of Section 368(a)(1)(F) of the Code, or a transaction of similar effect, shall not constitute a Change of Control.
d.    Good Reason     Executive’s termination of employment with the Company shall be for Good Reason if (i) Executive notifies the Company in writing that one of the Good Reason Events (as defined in subparagraphs d. i. and ii. below) has occurred, which notice shall be provided within ninety (90) days after he or she first becomes aware of the occurrence of such Good Reason Event; (ii) the Company fails to cure such Good Reason Event within thirty (30)days after receipt of the written notice from Executive (the “Cure Period”); and (iii) Executive resigns employment within thirty (30) days following expiration of the Cure Period.  For purposes of this Agreement, a “Good Reason Event” shall mean any of the following which occur without Executive’s consent:
i.    Prior to a Change of Control,

6

		
	A.
	The failure by the company to pay Executive any material amount of his or her current base salary, or any material amount of his or her compensation deferred under any plan, agreement or arrangement of or with the Company that is currently due and payable;

		
	B.
	A material reduction Executive’s annual base salary; 

		
	C.
	The relocation of Executive’s principal place of employment to a location more than fifty (50) miles from Executive’s current principal place of employment.

		
	D.
	A material adverse alteration of Executive’s duties and responsibilities; or

		
	E.
	An intentional, material reduction of Executive’s aggregate target incentive awards under any incentive plans.

ii.    During the two (2) year period following any Change of Control,
		
	A.
	The failure by the Company to pay Executive any material amount of his or her current base salary, or any material amount of his or her compensation deferred under any plan, agreement or arrangement of or with the Company that is currently due and payable;

		
	B.
	A material reduction in Executive’s annual base salary;

		
	C.
	The relocation of Executive’s principal place of employment to a location more than fifty (50) miles from Executive’s current principal place of employment;

		
	D.
	A material adverse alteration of Executive’s authority, duties or responsibilities from those in effect immediately prior to the Change of Control;

		
	E.
	An intentional, material reduction by the Company of Executive’s aggregate target incentive awards under any short-term and/or long term incentive plans; or

		
	F.
	The failure of the Company to maintain the Executive’s benefit, retirement, or fringe benefit plans, policies, practices or arrangements in which Executive participates (individually and collectively “Fringe Benefits”) at or above the level in effect immediately before the Change of Control, unless such change is a global change made to Fringe Benefits for all employees at or above Executive’s level.

7

e.    Code shall mean the Internal Revenue Code of 1986, as amended.

f.    Total Disability shall mean incapacity due to a medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continued period of not less than twelve (12) months and prevents Executive from performing the essential functions of his position, with or without reasonable accommodation, for a period in excess of twelve (12) months.
		
	8.
	Integration: Amendment.    This Agreement (including any Exhibits) shall constitute the entire agreement between the parties hereto with respect to the matters set forth herein and supersede and render of no force and effect all prior understandings and agreements between the parties with respect thereto.  No amendments or additions to this Agreement shall be binding unless in writing and signed by both parties, provided, however, that this Agreement may be unilaterally amended by the Company where necessary to ensure any benefits payable hereunder are either excepted from Code Section 409A or otherwise comply with Code Section 409A.

		
	9.
	Governing Law; Headings.    This Agreement will be construed and governed by the laws of the State of New Jersey, without regard to principles of conflicts of law and the parties to this Agreement hereby submit to the jurisdiction of the Courts of the State of New Jersey with regard to enforcement of this Agreement.

Headings and titles herein are included solely for convenience and shall not affect, or be used in connection with, the interpretation of this Agreement.
		
	10.
	Notices.  All notices and other communications required or permitted to be given or made hereunder by either party shall be in writing and shall be deemed to be duly given if delivered personally or transmitted by first class certified mail, postage and fees prepaid, return receipt requested, or sent by prepaid overnight delivery service to the parties at the following addresses (or at such other addresses as shall be specified by the parties by like notice):

    

8

If to the Company:
President
PDI, Inc.
Morris Corporate Center 1
Building A
300 Interpace Parkway
Parsippany, NJ 07054
If to the Executive:
Graham G. Miao, MBA, Ph.D.
[                            ]
[                            ]
		
	11.
	Severability.    Whenever possible, each provision and term of this Agreement will be interpreted in a manner to be effective and valid but if any provision or term of this Agreement is held to be prohibited by applicable law or invalid, then such provision or term will be ineffective only to the extent of such prohibition or invalidity, without invalidating or affecting in any manner whatsoever the remainder of such term or provision or the remaining provisions or terms of this Agreement.

		
	12.
	Counterparts.    This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement.

		
	13.
	Assignment.    The Company may assign all of its rights and obligations hereunder to an affiliate or subsidiary of the Company.

IN WITNESS WHEREOF the parties have duly executed this Agreement as of the date first above written.
EXECUTIVE
By:    /s/ Graham G. Miao                                    
Graham G. Miao
PDI, INC.
By:    /s/ Nancy S. Lurker                                    
Nancy S. Lurker
Chief Executive Officer

9Exhibit10.3

Exhibit 10.3

THIS CONFIDENTIAL INFORMATION, NON-DISCLOSURE, NON-COMPETITION, NON-SOLICITATION and RIGHTS TO INTELLECTUAL PROPERTY AGREEMENT (hereinafter the “Agreement”), dated as of the later of the signature dates below by and between Graham Miao, who currently resides at [                            ]  (“Employee”), and PDI, Inc., a New Jersey corporation, having its principal place of business at Morris Corporate Center 1-Building A/B, 300 Interpace Parkway, Parsippany, New Jersey 07054 (“Employer” or “PDI”).
WHEREAS, Employer is about to employ Employee in a position of trust and confidence to aid Employer in its Business (as hereinafter defined);
WHEREAS, Employer desires to receive from Employee a covenant not to disclose certain information relating to Employer’s Business and certain other covenants; 
WHEREAS, as a material inducement to Employer to employ Employee, and to pay the salary and other remuneration and provide benefits to Employee to be paid/provided by PDI, Employee has agreed to such covenants; and
WHEREAS, Employer and Employee desire to set forth, in writing, the terms and conditions of their agreements and understandings with respect to such covenants.
NOW, THEREFORE, in consideration of the foregoing, of the mutual promises herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto intending to be legally bound, agree as follows:
		
	1.
	Business.    PDI is a leading provider of integrated multi-channel promotional outsource services, which includes (outsourced) Dedicated Sales Teams, Shared Sales Teams, Clinical Educator Teams and Medical Science Liaison Teams, Marketing Services Segment and Product Commercialization Services, as well as other promotional services including tele-detailing, digital promotion including e-detailing, medical education and clinical 

1

educators throughout the United States of America for the pharmaceutical industry, as well as nutritional, diagnostic and other healthcare providers which services also include research and development activities (the “Business”).  The Business is highly competitive and specialized involving highly sensitive information.
		
	2.
	Term of Agreement.    This Agreement shall continue in full force and effect for the duration of Employee’s employment with PDI; provided, however, that after the termination of Employee’s employment with PDI this Agreement shall remain in effect until all of the obligations of the parties hereunder are satisfied or have expired.

		
	3.
	Employer.    As used herein, the terms“PDI” and “Employer” shall also include any business entity, which is at any time the parent ora subsidiary of PDI or any corporation or other entity, or which is an affiliate of PDI by virtue of common (although not identical) ownership, and for which Employee is providing services in any form during his/her employment with PDI or any such other corporation or entity including, but not limited to, Group DCA, L.L.C. (a foreign limited liability company qualified to do business in New Jersey) and Interpace BioPharma, L.L.C., a domestic New Jersey limited liability company.

		
	4.
	Notices.    Any notice required to, or permitted to, be given hereunder shall be sufficient if in writing (a) delivered personally, (b) sent by first class certified mail, return receipt requested, postage and fees prepaid, or (c) sent by prepaid overnight delivery service, to the parties at the following addresses (or at such other addresses as shall be specified by the parties in a like notice):

If to Employer:        PDI, Inc.
Morris Corporate Center I
Building A/B
300 Interpace Parkway
Parsippany, New Jersey 07054
Attn.:    Human Resources

		
	If to Employee:
	Notices to the Employee should be sent to the address indicated on page 1 of this document.

2

All notices shall be deemed to have been given upon receipt if delivered personally, or by recognized overnight courier, or five (5) days after mailing, if mailed.
		
	5.
	Confidential Information, Non-Disclosure.    The Employee understands and recognizes that his/her position with the Employer will afford the Employee substantial access to Confidential Information (as that term is defined below), the unauthorized use, disclosure and/or publication of which would cause the Employer to suffer substantial damage to and interfere with the current or contemplated Business of the Employer and may cause irreparable injury to Employer.  The Employee further understands and recognizes, therefore, that it is in the Employer’s legitimate business interest to restrict the Employee’s use of Confidential Information for any purposes other than the discharge of Employee’s duties at the Employer in furtherance of the Business, and to limit any potential appropriation of Confidential Information by the Employee for the benefit of the Employer’s competitors and to the detriment of the Employer.  Accordingly, the Employee agrees as follows:

3

		
	a.
	During and after the Employee’s employment with the Employer, the Employee will not, without the prior written consent of the Employer, or as may otherwise be required by law or legal process, communicate or disclose to any other person or company, nor use for the Employee’s own personal benefit, except as may be necessary in the performance of the Employee’s duties as an employee of the Employer, any Confidential Information disclosed to him or her or of which the Employee becomes aware or develops or is given access to by reason of the Employee’s employment or association with the Employer.

		
	b.
	The term “Confidential Information” means any and all data and information relating to the Employer and/or its Business (whether or not it constitutes a trade secret) or data and information received by the Employer from third parties including, but not limited to clients and business partners in confidence (or subject to a Non-Disclosure covenant), which is, or has been, disclosed to the Employee or of which the Employee became or becomes aware as a consequence of his or her employment relationship with the Employer and which has value to the Employer and is not generally known by its competitors including, but not limited to, information concerning PDI’s integrated multi-channel promotional services, other promotional services including teledetailing, digital promotions including e-detailing, medical education and clinical coordinators, digital network systems, business and marketing plans, long range goals and objectives, assets and liabilities, technical and engineering

4

methodology, processes, and/or know how, research and development activities, products, computer software and programs, marketing data, discounts and pricing, functional specifications and financial or business affairs of the Employer relating to services, clients, client lists, employees or employee compensation projections, plans/development, accounting and marketing studies or analysis, and information of third parties, which the Employer is required to maintain as confidential.  Confidential Information shall not include any data or information that has been disclosed voluntarily to the public by the Employer (except when such public disclosure has been made by the Employee or some other person without authorization from the Employer), or that has been independently developed and disclosed by others, or that otherwise enters the public domain through lawful and legitimate means.  
The Employee hereby expressly agrees that Confidential Information is the exclusive property of the Employer, to be held by the Employee in trust and solely for the Employer’s benefit and shall not be used by the Employee or disclosed by the Employee to others, either during or after the Employee’s employment, without the Employer’s advance written consent or except where required for the Employee to properly perform the Employee’s job duties for the Employer.  This promise is binding on the Employee regardless of the reason(s) for the termination of the Employee’s employment.  The Employee further agrees to comply with all rules, policies and procedures established by the Employer from time-to-time, 

5

which are designed to protect and ensure the continued confidentiality of the Confidential Information.
		
	c.
	The Employee understands and agrees that upon termination of the Employee’s employment with the Employer, the Employee will not take with him/her, or retain without written authorization from the Employer, any documents, files or other property of the Employer, and the Employee will promptly return to the Employer any such documents, files or property in his/her possession or control, including all copies, extracts, reproductions or notes, as may have been made by or on behalf of the Employee.  If the Employee has stored Confidential Information on any personal desktop or laptop devices, Personal Digital Assistants (“PDAs”), mobile/smart phones, external hard drives, “flash” or similar USB storages devices, Fire Wire storage devices, digital music players, digital tapes, floppy diskettes, CDs, DVDs, memory cards, zip diskettes, as well as maintained in personal e-mail accounts (including web based e-mail accounts such as Hotmail, Gmail, Yahoo, etc.) and other electronic or online communications applications, such as text messaging, social media networks (i.e. Facebook, Linked In, My Space, etc.), chat rooms and similar environments and all other media, which can be utilized to store or transmit electronic data and communications (regardless of whether the media utilized is owned by the Employer, the Employee or a third party, or where the media is located) then the Employee must make those devices available to the Employer or provide access to those accounts or communications in order to enable the Employer to search for such Confidential Information and to remove and/or make complete copies of the media/communications and all information stored.  

6

Employee acknowledges and agrees that this list is not comprehensive and includes technological advancements in methods, devices and locations for storing and communicating data that could include Confidential Information covered by this provision.  For this purpose, the Employee agrees that he/she has no expectation of privacy with respect to the various media and communications referred to above.
In connection with this Agreement, the Employee recognizes that all documents, files and property, which Employee has received and will receive from the Employer including, but not limited to, handbooks, memoranda, policy manuals, product specifications and other materials, with the exception of documents relating to benefits to which the Employee might be entitled to, following the termination of his/her employment with the Employer, are for the exclusive use of the Employer and employees discharging their responsibilities on behalf of the Employer, and that the Employee has no claim or right to the continued use, possession or custody of such material following the termination of his/her employment with Employer.
If Employee becomes legally compelled (by deposition, Interrogatory, request for documents, Subpoena, civil investigative demand or similar process) to disclose any Confidential Information, Employee shall provide Employer with prompt written notice of such requirement so Employer may seek a protective order or other appropriate remedy and/or waive compliance with the terms of this Paragraph 5 of this Agreement.  If such protective order or other remedy is not obtained, or Employer waives compliance with the provisions of this Paragraph 5, Employee agrees to furnish only that portion of the Confidential Information, which he/she is advised by written opinion of legal counsel is legally required and to exercise best efforts to obtain assurances that confidential treatment will be accorded such Confidential Information.

7

		
	6.
	Non-Solicitation.    Except as otherwise approved in writing by Employer, Employeeagrees that Employee will not, directly or indirectly, with or through any family member, or former directors, officers or employees of Employer, or acting alone or as a member of a partnership or limited liability company or as an officer, holder of or investor in as much as five (5%) percent of any security of any class, director, employee, consultant or representative of any corporation or other business entity (i) at any time whilst engaged as an employee of the Employer, and for a period of 1 year following termination as an employee, interfere with, or seek to interfere with the relationship or otherwise alter, limit or terminate such relationship between the Employer and the following: (a) any of the employees of the Employerat any time within 6 months prior to the cessation of Employee’s employment with the Employer, such as inducing or attempting to induce any employee to leave employment with the Employer or hire any such employee; (b) any of the customers or clients of the Employer then existing or existing at any time within6 months prior to the cessation of Employee’s employment with the Employer with which Employee personally had contact or access to Confidential Information about, or (c) any of the suppliers or licensees of the Employer, then existing or existing at any time within 6 months prior to cessation of the Employee’s employment with the Employer.

		
	7.
	Non-Competition.    It is recognized and understood by the parties hereto that Employee, through Employee’s association with the Employer as an Employee, shall acquire a considerable amount of knowledge and goodwill with respect to the Business of the Employer, as well as access to the Employer’s clients, which knowledge, goodwill and relationships are extremely valuable to Employer and which would be extremely detrimental to Employer if used by Employee to compete with Employer.  It is therefore understood and agreed to by the parties hereto that because of the nature of the Business of the Employer, it is necessary to afford fair protection to Employer from competition by Employee.  Consequently, as a material 

8

inducement to employ Employee, Employee covenants and agrees that he/she will not, directly or indirectly, with or through any family member, or former director, officer or employee of Employer, or acting alone or as a member of a partnership or limited liability company, or as an officer of or investor in as much as five (5%) percent of any security of any class, director, employee, consultant or representative of any corporation or other business entity (i) at any time while engaged as an employee of the Employer, and for a period of 1 year following cessation as an employee for any reason, whether at the insistence of either the Employer or Employee, own, manage operate, control, consult with, or be employed by or with any person, firm, partnership, association, corporation or other business entity which competes with the Employer or performs services which are substantially similar to the Employer’s in the biopharmaceutical or medical devices and diagnosis industries (including, but not limited to provision of any dedicated sales teams, shared sales teams,clinical teams or any combination of teams) in any State in which the Employee worked, provided services or performed employment duties for the Employer during the Employee’s last 1 year of employment with the Employer or any commercialization provider serving the biopharmaceutical, medical devices and/or diagnostic industries that directly compete with a product or which Employee worked, performed services or performed employment duties for the Employer during the Employee’s last year of employment with the Employer.
		
	8.
	Rights to Intellectual Property.    All inventions, improvements, modifications, ideas, styles, trade names and the like, whether or not reduced to writing or stored electronically or otherwise and whether or not protectable by patent, trademark, copyright or other intellectual property law, which relate or are susceptible for use directly or indirectly in the Employer’s Business that are originated in whole, or in part, by Employee (alone or jointly with others) during his/her term of employment with the Employer, irrespective of whether they were conceived, developed, suggested or perfected (i) during the Employee’s regular working 

9

hours, (ii) with the use of Employer’s time, materials or facilities or (iii) within one (1) year following the termination of Employee’s employment with Employer or otherwise attributable to Employee’s employment with Employer shall become and remain the exclusive property of the Employer.  If any one or more of the aforementioned are deemed in any way to fall within the definition of “work made for hire,” as such term is defined in 17 U.S.C. §101, such work shall be considered a “work made for hire,” the copyright of which shall be owned solely by, or assigned or transferred completely and exclusively to Employer.  At the request and expense of the Employer, the Employee shall cooperate with the Employer, in applying for, prosecuting, and obtaining patent, trademark, service mark, trade name and copyright registrations in the name of the Employer.
The Employee shall promptly disclose, grant and assign ownership to the Employer, for its sole use and benefit any and all inventions, improvements, information and copyrights (whether patentable or not), which he/she may develop, acquire, conceive or reduce to practice, while employed by the Employer (whether or not during usual working hours) together with all patent applications, letters, patent, copyrights and reissues thereof, that may at any time be granted for or upon any such invention, improvement or information; provided, however, that Employee shall own any invention, which Employee can demonstrate has no relationship to the Business, and which was neither conceived, nor made by use of any of the time, facilities or materials of the Employer.  In connection therewith:
		
	(i)
	The Employee shall without charge, but at the expense of the Employer, promptly at all times thereafter execute and deliver such applications, assignments, descriptions and other instruments, as may be reasonably necessary or proper in the opinion of the Employer to vest title to any such inventions, improvements, technical information, patent applications, patents, copyrights or reissues thereof in the Employer, and to enable it to obtain and maintain the entire right and title thereto through the word; and

10

		
	(ii)
	The Employee shall render to the Employer at its expense (including reimbursement to the Employee of reasonable out-of-pocket expenses incurred by the Employee and a reasonable payment for the Employee’s time involved in case he/she is not then in its employ) all such assistance as it may require in the prosecution of applications for said patents, copyright or reissues thereof, in the prosecution, or defense of interferences, which may be declared involving any said applications, patents or copyrights and in any litigation in which the Employer may be involved relating to any such patents, inventions, improvements or technical improvements.

In the event that the Employer is unable to, after reasonable effort, secure the Employee’s signature on any document(s) needed to apply for or secure any copyright or patent, for any reason whatsoever, Employee hereby designates the Employer, and its duly authorized officers and agents, as Employee’s agent and attorney-in-fact to execute and file any such application(s), and to perform all other legally permitted acts to further the prosecution and issuance of copyrights and patents, or similar protection thereon, which shall have the same legal form and effect as if executed by Employee.
Employee hereby represents and warrants that Employee has fully described to Employer on Schedule A appended hereto any idea, invention, product, improvement, computer software program or other equipment or technology related to the Business of the Employer (“Inventions”), not covered in this Paragraph 8, which prior to his/her employment with the Employer, Employee conceived of or developed, wholly or in part, and in which Employee has any right, title or proprietary interest, and whether directly related to Employer’s Business, but which has not been published or filed with the United States Patent or Copyright offices or assigned or transferred to Employer.  If there is no such Schedule A, Employee represents that Employee has 

11

made no such Inventions at the time of signing this Agreement or Employee hereby assigns such Inventions to Employer.
With respect to this Paragraph 8, it is agreed and acknowledged that during the Employee’s employment, Employer may enter other lines of business, which are related or unrelated to its current line of business, in which case this Agreement would be expanded to cover such new lines of business.
In the event that the Employer gives written notice to the Employee that the Employer elects not to apply for a patent in a jurisdiction for an item above, which is patentable then Employee may, at his or her own cost and expense, apply for a patent therefor inhisor her own name in such jurisdiction.
		
	9.
	Reasonableness of Restrictions.

		
	a.
	Employee has carefully read and considered the provisions of Paragraphs 5 through 8 hereof, and having done so agrees that the restrictions set forth therein are fair and reasonable and are reasonably required for the protection of the interests of the Employer, its stockholders, directors, officers and employees and that the Employer would not have entered into this Agreement in the absence of such restrictions and that any violation of any provisions of Paragraphs 5 through 8 will result in irreparable injury to the Employer.  Employee further represents and acknowledges that (i) Employee has been advised by the Employer to consult his/her counsel prior to execution and delivery of this Agreement, and (ii) that the Employee has had full opportunity, prior to execution and delivery of this Agreement, to review thoroughly this Agreement with his/her counsel.Employee further understands and agrees that the Employer shall be entitled to preliminary and permanent injunctive relief, without the necessity of proving actual damages, as well as an equitable accounting of all earnings, profits and other benefit, arising from any violation of Paragraphs 5 through 8, whic

12

h rights shall be cumulative, and in addition to any other rights or remedies to which the Employer may be entitled hereunder or now or hereafter existing in law or equity.  No delay or omission by a party hereto in exercising any right, remedy or power hereunder or existing at law or in equity shall be construed as a waiver thereof.
		
	b.
	To the extent any portion of any provision of this Agreement is held to be invalid or unenforceable, the language shall be construed by limiting and/or reducing it so as to be enforceable to the extent compatible with applicable law.  All remaining provisions and/or portions thereof shall remain in full force and effect.

		
	10.
	Binding Effect.    This Agreement shall be binding upon and inure to the benefit of and be enforceable by, Employer and its successors and assigns, and shall be binding upon and inure to the benefit of and be enforceable by the Employee and his or her estate, heirs, administrators and legal representatives.  This Agreement is not assignable by Employee but is assignable by Employer to any successor to all, or substantially all, of its Business, assets or other reorganization to which it may become a party, provided that, such assignee assumes all of the obligations of the Employer hereunder.

		
	11.
	Entire Agreement and Amendment.

 This Agreement, together with its attachment and any other collateral agreements executed in connection herewith contain the entire agreement between the Employer and Employee with respect to the restrictive covenants set forth in Paragraphs 5 through 8hereof and supersedes all prior agreements, written or oral, with respect thereto.  This Agreement cannot be changed, modified, extended or terminated, except upon written amendment executed by Employee and executed on the Employer’s behalf by a duly authorized officer.
Nothing in this Agreement shall be construed as giving the Employee any right to be retained by the Employer, or as changing or modifying the “at will” nature of the Employee’s 

13

employment with the Employer.  This means that the Employee’s employment with the Employer may be terminated, at any time by either party, without notice or reason.
		
	12.
	Governing Law, Consent to Jurisdiction.    This Agreement shall be governed by, and construed in accordance with, the laws of the State of New Jersey, without regard to its conflicts of law provisions.Any claim arising out of, or relating to this Agreement including, without limitation, any action commenced by Employer for preliminary and permanent injunctive relief or other equitable relief, shall be instituted in state court in the State of New Jersey, and each party agrees not to assert by way of motion, as a defense or otherwise, in any such claim, that it is not subject personally to the jurisdiction of such court, that the claim is brought in an inconvenient forum, that the venue of the claim is improper or that this Agreement or the subject matter, hereof may not be enforced in or by such court.  Each party further irrevocably submits to the exclusive jurisdiction of such court in any such claim.

Any and all service of process and any other notice in any such claim shall be effective against any party if given personally or by registered mail, return receipt requested, mailed to such party as provided herein.  Nothing herein contained shall be deemed to affect the right of any party to serve process in any manner permitted by law.
		
	13.
	Usage.        All pronouns and any variations thereof referred to in the masculine, feminine or neuter, singular or plural, as the context may require.  All terms defined in the Agreement in their singular or plural forms have correlative meanings when used herein in their singular or plural forms, respectively.  Unless otherwise expressly provided the words “include” “includes” and “including” do not limit the preceding words or terms and shall be deemed followed by the words “without limitation”.

		
	14.
	Headings.    The headings in this Agreement are for reference only, and shall not affect the interpretation of this Agreement.

14

		
	15.
	Counterparts.    This Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts, together shall constitute one, and the same, instrument.  Each counterpart may consist of a member of copies hereof each signed by less than all, but together signed by all of the parties hereto.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK, SIGNATURES OF NEXT PAGE]
    

15

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year first above written.
	
				
	Employee
	 
	 
	PDI, Inc

	 
	 
	 
	 

	 
	 
	 
	 

	/s/ Graham Miao
	 
	By:
	/s/ Jennifer Leonard

	Graham Miao
	 
	Name:
	Jennifer Leonard

	 
	 
	Title:
	SVP, Human Resources and IT

	Dated: 10/14/14
	 
	Dated:
	10/14/14

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]